Integrated Investment Consultants’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,187
Closed -$384K 296
2025
Q3
$384K Buy
1,187
+145
+14% +$45.1K 0.07% 188
2025
Q2
$405K Sell
1,042
-6
-0.6% -$2.41K 0.08% 171
2025
Q1
$456K Buy
1,048
+21
+2% +$8.43K 0.09% 166
2024
Q4
$379K Buy
1,027
+2
+0.2% +$837 0.08% 199
2024
Q3
$533K Buy
+1,025
New +$548K 0.12% 129
2022
Q2
Sell
-429
Closed -$211K 268
2022
Q1
$211K Buy
+429
New +$196K 0.06% 276
2018
Q2
Sell
-43
Closed -$9K 318
2018
Q1
$9K Buy
+43
New +$10.1K ﹤0.01% 643
2017
Q3
$204K Sell
1,075
-75
-7% -$14.3K 0.09% 153
2017
Q2
$216K Hold
1,150
0.1% 138
2017
Q1
$190K Buy
1,150
+300
+35% +$47.7K 0.09% 157
2016
Q4
$122K Hold
850
0.06% 227
2016
Q3
$103K Hold
850
0.05% 254
2016
Q2
$112K Buy
850
+150
+21% +$20.5K 0.06% 238
2016
Q1
$101K Buy
+700
New +$93.5K 0.06% 233

Other funds holding ELV

Integrated Investment Consultants's ELV Position: Q4 2025 in Review

Integrated Investment Consultants sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 1,187 shares — an estimated $384K sold.

Integrated Investment Consultants first reported a position in ELV in Q1 2016 and held it in 14 quarters. The position peaked at $533K in Q3 2024. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Integrated Investment Consultants reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Integrated Investment Consultants sold 1,187 Elevance Health shares in Q4 2025, an estimated $384K.
  • Integrated Investment Consultants first reported a position in Elevance Health in Q1 2016 and held it in 14 quarters.
  • Integrated Investment Consultants's Elevance Health position peaked at $533K in Q3 2024.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Integrated Investment Consultants's 13F filing for Q4 2025, filed 5 Feb 2026.